Here, as part of an ongoing effort to understand the relationship between MFN2 mutation site, protein dysfunction, and disease manifestation, we screened cardiomyopathy research cohorts for MFN2 mutations linked to cardiac hypertrophy or heart failure. The gene discussed is MFN2; the disease is cardiac hypertrophy.